It is known that inhibitors of CYP1B1 (which produces cardiotoxic metabolites), e.g., resveratrol (known for its antioxidant and cardioprotective effects) can be therapeutic agents for hypertension [31]. This evidence concerns the gene CYP1B1 and hypertensive disorder.